In another report, the antitumor effect of IFN-β was offset by the tumor-progressive character of endothelial progenitor cells (EPCs) and the tumor growth, and the vascular density of tumor tissues increased by the co-implanted EPCs were decreased upon IFN-β treatment. The gene discussed is IFNB1; the disease is neoplasm.